The global stem cell assay market was valued at over US$ 450.0 Mn. in 2017 and is anticipated to grow at a CAGR of 19.9% from 2019 to 2030. The major factors driving the growth of the market includes increasing burden of chronic diseases, growing investment in R&D, and technological developments in biotech and pharmaceutical industry.
Major Players in the market focusing on R&D
Key players operating in the global stem cell assay market are Thermo Fisher Scientific, Promega Corporation, STEMCELL Technologies Inc., Merck KGaA, GE Healthcare, Bio-Techne Corporation, Hemogenix, Bio-Rad Laboratories, Inc., Cellular Dynamics International Inc., and Cell Biolabs Inc.
No comments:
Post a Comment